The report says 4 countries accounted for more than half of the global number of people estimated to have developed multidrug-resistant or rifampicin-resistant tuberculosis in 2024
The report says 4 countries accounted for more than half of the global number of people estimated to have developed multidrug-resistant or rifampicin-resistant tuberculosis in 2024